Contralateral Breast Cancer Risk among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2

  1. Yadav, S.
  2. Boddicker, N.J.
  3. Na, J.
  4. Polley, E.C.
  5. Hu, C.
  6. Hart, S.N.
  7. Gnanaolivu, R.D.
  8. Larson, N.
  9. Holtegaard, S.
  10. Huang, H.
  11. Dunn, C.A.
  12. Teras, L.R.
  13. Patel, A.V.
  14. Lacey, J.V.
  15. Neuhausen, S.L.
  16. Martinez, E.
  17. Haiman, C.
  18. Chen, F.
  19. Ruddy, K.J.
  20. Olson, J.E.
  21. John, E.M.
  22. Kurian, A.W.
  23. Sandler, D.P.
  24. O'Brien, K.M.
  25. Taylor, J.A.
  26. Weinberg, C.R.
  27. Anton-Culver, H.
  28. Ziogas, A.
  29. Zirpoli, G.
  30. Goldgar, D.E.
  31. Palmer, J.R.
  32. Domchek, S.M.
  33. Weitzel, J.N.
  34. Nathanson, K.L.
  35. Kraft, P.
  36. Couch, F.J.
  37. Mostra tots els autors/es +
Revista:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Any de publicació: 2023

Volum: 41

Número: 9

Pàgines: 1703-1713

Tipus: Article

DOI: 10.1200/JCO.22.01239 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus